Insmed Inc
NASDAQ:INSM

Watchlist Manager
Insmed Inc Logo
Insmed Inc
NASDAQ:INSM
Watchlist
Price: 70.6 USD 0.66% Market Closed
Market Cap: 12.1B USD
Have any thoughts about
Insmed Inc?
Write Note

Insmed Inc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Insmed Inc
Interest Income Expense Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Insmed Inc
NASDAQ:INSM
Interest Income Expense
-$43.9m
CAGR 3-Years
-11%
CAGR 5-Years
-22%
CAGR 10-Years
-35%
Abbvie Inc
NYSE:ABBV
Interest Income Expense
-$2B
CAGR 3-Years
7%
CAGR 5-Years
-9%
CAGR 10-Years
-13%
Gilead Sciences Inc
NASDAQ:GILD
Interest Income Expense
-$948m
CAGR 3-Years
26%
CAGR 5-Years
-6%
CAGR 10-Years
-10%
Amgen Inc
NASDAQ:AMGN
Interest Income Expense
-$2.4B
CAGR 3-Years
-34%
CAGR 5-Years
-29%
CAGR 10-Years
-15%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Interest Income Expense
$595.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Interest Income Expense
$990m
CAGR 3-Years
23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Insmed Inc's Interest Income Expense?
Interest Income Expense
-43.9m USD

Based on the financial report for Jun 30, 2024, Insmed Inc's Interest Income Expense amounts to -43.9m USD.

What is Insmed Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
-35%

Over the last year, the Interest Income Expense growth was -53%. The average annual Interest Income Expense growth rates for Insmed Inc have been -11% over the past three years , -22% over the past five years , and -35% over the past ten years .

Back to Top